Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.47 USD | +0.87% | +30.82% | +33.07% |
May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
May. 08 | Myriad Genetics Shares Rise After Reporting Narrower Q1 Adjusted Loss, Higher Revenue | MT |
Evolution of the average Target Price on Myriad Genetics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Myriad Genetics, Inc.
BofA Securities | |
Goldman Sachs | |
Wells Fargo Securities | |
Wolfe Research | |
JPMorgan Chase | |
Morningstar | |
Jefferies & Co. | |
Stephens Inc. | |
Raymond James | |
SVB Securities LLC |
EPS Revisions
- Stock Market
- Equities
- MYGN Stock
- Consensus Myriad Genetics, Inc.